Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Trichinella spiralis muscle larvae release extracellular vesicles with immunomodulatory properties.

Kosanović M, Cvetković J, Gruden-Movsesijan A, Vasilev S, Svetlana M, Ilić N, Sofronić-Milosavljević L.

Parasite Immunol. 2019 Oct;41(10):e12665. doi: 10.1111/pim.12665. Epub 2019 Sep 10.

PMID:
31356691
2.

Domain Diversity and Polarization Switching in Amino Acid β-Glycine.

Vasileva D, Vasilev S, Kholkin AL, Shur VY.

Materials (Basel). 2019 Apr 15;12(8). pii: E1223. doi: 10.3390/ma12081223.

3.

Diphenylalanine-Based Microribbons for Piezoelectric Applications via Inkjet Printing.

Safaryan S, Slabov V, Kopyl S, Romanyuk K, Bdikin I, Vasilev S, Zelenovskiy P, Shur VY, Uslamin EA, Pidko EA, Vinogradov AV, Kholkin AL.

ACS Appl Mater Interfaces. 2018 Mar 28;10(12):10543-10551. doi: 10.1021/acsami.7b19668. Epub 2018 Mar 15.

PMID:
29498259
4.

A competitive enzyme-linked immunosorbent assay for rapid detection of antibodies against Trichinella spiralis and T. britovi - one test for humans and swine.

Gnjatovic M, Gruden-Movsesijan A, Miladinovic-Tasic N, Ilic N, Vasilev S, Cvetkovic J, Sofronic-Milosavljevic L.

J Helminthol. 2019 Jan;93(1):33-41. doi: 10.1017/S0022149X17001092. Epub 2017 Nov 23.

PMID:
29168448
5.

Self-Assembly of Organic Ferroelectrics by Evaporative Dewetting: A Case of β-Glycine.

Seyedhosseini E, Romanyuk K, Vasileva D, Vasilev S, Nuraeva A, Zelenovskiy P, Ivanov M, Morozovska AN, Shur VY, Lu H, Gruverman A, Kholkin AL.

ACS Appl Mater Interfaces. 2017 Jun 14;9(23):20029-20037. doi: 10.1021/acsami.7b02952. Epub 2017 Jun 2.

PMID:
28534399
6.

On the origin of the great rigidity of self-assembled diphenylalanine nanotubes.

Zelenovskiy P, Kornev I, Vasilev S, Kholkin A.

Phys Chem Chem Phys. 2016 Nov 2;18(43):29681-29685.

PMID:
27775117
7.

The first report of Trichinella pseudospiralis presence in domestic swine and T. britovi in wild boar in Bosnia and Herzegovina.

Santrac V, Nedic DN, Maric J, Nikolic S, Stevanovic O, Vasilev S, Cvetkovic J, Sofronic-Milosavljevic L.

Acta Parasitol. 2015 Sep;60(3):471-5. doi: 10.1515/ap-2015-0066.

PMID:
26204186
8.

Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction.

Vasilev S, Ilic N, Gruden-Movsesijan A, Vasilijic S, Bosic M, Sofronic-Milosavljevic L.

Cent Eur J Immunol. 2015;40(1):42-53. doi: 10.5114/ceji.2015.50832. Epub 2015 Apr 22.

9.

Fabric-based exocervical and endocervical biopsy in comparison with punch biopsy and sharp curettage.

Winter M, Cestero RM, Burg A, Felix JC, Han C, Raffo AM, Vasilev S.

J Low Genit Tract Dis. 2012 Apr;16(2):80-7. doi: 10.1097/LGT.0b013e318234262d.

PMID:
22371040
10.

Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer.

Mahdavi A, Tajalli TR, Dalmar A, Vasilev SA, Lentz SE, Berman ML.

Int J Gynecol Cancer. 2011 Nov;21(8):1436-40. doi: 10.1097/IGC.0b013e31822e7588.

PMID:
21997174
11.

The impact of Trichinella spiralis excretory-secretory products on dendritic cells.

Gruden-Movsesijan A, Ilic N, Colic M, Majstorovic I, Vasilev S, Radovic I, Sofronic-Milosavljevic Lj.

Comp Immunol Microbiol Infect Dis. 2011 Sep;34(5):429-39. doi: 10.1016/j.cimid.2011.08.004. Epub 2011 Sep 7.

PMID:
21903269
12.

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS.

Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.

PMID:
19820372
13.

Strain difference in susceptibility to Trichinella spiralis infection between dark agouti and albino oxford rats.

Vasilev S, Gruden-Movsesijan A, Ilic N, Sofronic-Milosavljevic LJ.

Vet Parasitol. 2009 Feb 23;159(3-4):229-31. doi: 10.1016/j.vetpar.2008.10.042. Epub 2008 Oct 22.

PMID:
19041181
14.

Characterization of rat bone marrow dendritic cells initially primed by Trichinella spiralis antigens.

Ilic N, Colic M, Gruden-movsesijan A, Majstorovic I, Vasilev S, Sofronic-Milosavljevic Lj.

Parasite Immunol. 2008 Sep;30(9):491-5. doi: 10.1111/j.1365-3024.2008.01049.x.

15.

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):373-8.

PMID:
17362315
16.

Uterine effects of tamoxifen: a prospective study.

McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, Roy S, Wong PT, Simpson JF, Wilczynski SP.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):814-20.

PMID:
16681767
17.

Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers.

Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH.

Gynecol Oncol. 2006 Apr;101(1):120-5. Epub 2005 Nov 22.

PMID:
16307792
18.

Dendritic cells acquire tolerogenic properties at the site of sterile granulomatous inflammation.

Vasilijić S, Savić D, Vasilev S, Vucević D, Gasić S, Majstorović I, Janković S, Colić M.

Cell Immunol. 2005 Feb;233(2):148-57.

PMID:
15978562
19.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.

Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, Disaia PJ.

Gynecol Oncol. 2005 Jan;96(1):204-9.

PMID:
15589602
20.

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.

Cancer Chemother Pharmacol. 2004 Oct;54(4):283-9. Epub 2004 Jun 4.

PMID:
15184995

Supplemental Content

Loading ...
Support Center